Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
CHELSEA THERAPEUTICS (NASDAQ: CHTP)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Results From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 20th Annual International Symposium on the Autonomic Nervous System
Nov 12, 2009 07:36 AM |
CHTP
Chelsea Therapeutics Reports Third Quarter 2009 Results
Nov 02, 2009 04:17 PM |
CHTP
Chelsea Therapeutics Appoints Dr. William D. Schwieterman Chief Medical Officer
Nov 02, 2009 07:31 AM |
CHTP
Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2009 Results
Oct 28, 2009 09:05 AM |
CHTP
Chelsea Therapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009
Oct 27, 2009 07:31 AM |
CHTP
Chelsea Therapeutics Presents Novel, Metabolically Inert Autoimmune Portfolio at the 2009 ACR Annual Scientific Meeting
Oct 20, 2009 07:32 AM |
CHTP
Chelsea Therapeutics to Host Conference Call to Discuss Droxidopa Phase III Results Today At 4:30 PM ET
Oct 01, 2009 04:01 PM |
CHTP
US Hot Stocks: CMCSA, LWSN, UAUA, PAG, CHTP
Oct 01, 2009 02:44 PM |
CHTP
,
CMCSA
,
LWSN
,
PAG
,
UAUA
Additional Analysis Confirms Significant Symptomatic Benefit of Droxidopa in Treatment of Neurogenic Orthostatic Hypotension
Oct 01, 2009 07:01 AM |
CHTP
Skymark Research Initiates Independent Research Coverage On Chelsea Therapeutics International, Ltd.
Sep 25, 2009 09:17 AM |
CHTP
More..
Chelsea Therapeutics Q3 Net Loss Narrows
Nov 03, 2009 10:55 AM |
CHTP
Chelsea Therapeutics Secures $13.3 Million in Registered Direct Offering
Jul 30, 2009 10:51 AM |
CHTP
More..
Chelsea Therapeutics Reports Second Quarter 2009 Results
Aug 05, 2009 07:31 AM |
CHTP
Chelsea Therapeutics to Host Conference Call to Discuss Second Quarter 2009 Results
Jul 30, 2009 07:54 AM |
CHTP
Chelsea Therapeutics Completes $13.3 Million in Registered Direct Offering
Jul 29, 2009 08:39 AM |
CHTP
Chelsea Therapeutics Appoints William Rueckert to Board of Directors
Jul 28, 2009 07:25 AM |
CHTP
Chelsea Therapeutics to Raise $12.6 Million in Registered Direct Offering
Jul 23, 2009 08:50 AM |
CHTP
Chelsea Therapeutics Achieves Target Enrollment in Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension
Jun 30, 2009 07:28 AM |
CHTP
Chelsea Therapeutics Added to Russell 3000 and Russell 2000 Indexes
Jun 29, 2009 04:30 PM |
CHTP
Chelsea Therapeutics to Present Data Demonstrating Efficacy of CH-4051 in Rat Collagen-Induced Arthritis Model at EULAR 2009
Jun 11, 2009 07:31 AM |
CHTP
Chelsea Therapeutics to Present Phase II Intradialytic Hypotension Data in Late Breaking Clinical Trials Session At World Congress of Nephrology 2009
May 21, 2009 07:25 AM |
CHTP
Chelsea Therapeutics Reports First Quarter 2009 Results
May 06, 2009 07:30 AM |
CHTP
More..
Form 4 Chelsea Therapeutics For: Nov 10 Filed by: AUSTIN JOSIAH T (10K)
Nov 12, 2009 01:05 PM
Form 4 Chelsea Therapeutics For: Nov 06 Filed by: AUSTIN JOSIAH T (10K)
Nov 10, 2009 12:05 PM
Form 4 Chelsea Therapeutics For: Nov 04 Filed by: AUSTIN JOSIAH T (10K)
Nov 09, 2009 06:45 PM
Form 4 Schwieterman William D For: Oct 29 (10K)
Nov 02, 2009 05:25 PM
Form 4 Chelsea Therapeutics For: Oct 23 Filed by: El Coronado Holdings, LLC (10K)
Oct 27, 2009 02:03 PM
Form 4 Chelsea Therapeutics For: Oct 19 Filed by: El Coronado Holdings, LLC (10K)
Oct 21, 2009 02:36 PM
Form 4 Chelsea Therapeutics For: Oct 08 Filed by: AUSTIN JOSIAH T (10K)
Oct 13, 2009 06:20 PM
Form 4 Chelsea Therapeutics For: Oct 06 Filed by: El Coronado Holdings, LLC (10K)
Oct 08, 2009 04:38 PM
Form 4 Chelsea Therapeutics For: Sep 30 Filed by: AUSTIN JOSIAH T (10K)
Oct 02, 2009 05:27 PM
Form 4 Chelsea Therapeutics For: Sep 28 Filed by: AUSTIN JOSIAH T (10K)
Sep 30, 2009 05:21 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
CHTP
Compare to S&P
YTD
64.18 %
35.62 %
4 Weeks
-23.88 %
-24.28 %
12 Weeks
-58.88 %
-61.41 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
29.03 %
EPS Growth in Last Year:
18.52 %
Sales Growth in Last Quarter:
-0.01 %
Sales Growth in Last Quarter:
-0.01 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
